Yue Wu Selected Research

N-acetylneuraminate synthase

1/2022

Genome-wide CRISPR-Cas9 screening identifies the CYTH2 host gene as a potential therapeutic target of influenza viral infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue Wu Research Topics

Disease

125	Neoplasms (Cancer) 09/2022 - 11/2004
42	Inflammation (Inflammations) 01/2022 - 01/2014
25	Neoplasm Metastasis (Metastasis) 03/2022 - 10/2010
25	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2005
23	Breast Neoplasms (Breast Cancer) 02/2022 - 09/2012
19	Infections 06/2022 - 10/2016
18	Hypoxia (Hypoxemia) 05/2022 - 01/2004
17	Atherosclerosis 11/2021 - 02/2010
15	Carcinogenesis 03/2022 - 05/2008
14	Myocardial Infarction 10/2021 - 10/2011
14	Hemorrhage 01/2021 - 11/2013
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 10/2010
13	Sepsis (Septicemia) 03/2022 - 01/2016
13	Glioma (Gliomas) 02/2022 - 02/2014
13	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2010
12	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 02/2017
12	Hemorrhagic Shock 01/2022 - 11/2013
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2016
12	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 01/2010
12	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 05/2015
11	Cognitive Dysfunction 01/2021 - 03/2014
10	Hypertension (High Blood Pressure) 07/2022 - 04/2014
10	Fibrosis (Cirrhosis) 01/2022 - 01/2014
10	Heart Failure 01/2022 - 07/2013
9	Stroke (Strokes) 10/2022 - 03/2015
9	Type 2 Diabetes Mellitus (MODY) 07/2022 - 09/2017
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 08/2011
9	Atrial Fibrillation 01/2022 - 12/2016
9	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2017
9	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 01/2016
9	Ischemia 01/2021 - 08/2005
8	Neuroinflammatory Diseases 12/2022 - 09/2015
8	Brain Injuries (Brain Injury) 01/2021 - 01/2016
8	Wounds and Injuries (Trauma) 01/2021 - 11/2013
8	Shock 12/2020 - 01/2016
7	COVID-19 11/2022 - 08/2020
7	Parkinson Disease (Parkinson's Disease) 01/2022 - 07/2019
7	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 06/2013
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 10/2010
7	Acute Coronary Syndrome 01/2021 - 03/2011
7	Asthma (Bronchial Asthma) 01/2020 - 10/2013
6	Glaucoma 12/2022 - 09/2011
6	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 03/2015
6	Chronic Renal Insufficiency 01/2021 - 01/2017
6	Brain Edema (Cerebral Edema) 01/2021 - 06/2014
6	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2016
6	Ischemic Stroke 01/2021 - 12/2015
6	Deafness (Deaf Mutism) 12/2020 - 06/2012
6	Hearing Loss (Hearing Impairment) 12/2020 - 06/2012
6	Stomach Neoplasms (Stomach Cancer) 10/2020 - 06/2018
5	Reperfusion Injury 12/2022 - 11/2016

Drug/Important Bio-Agent (IBA)

53	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2005
32	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2010
28	Pharmaceutical PreparationsIBA 08/2022 - 10/2010
24	LipidsIBA 06/2022 - 02/2015
17	Apolipoproteins E (ApoE)IBA 01/2021 - 02/2010
16	EnzymesIBA 01/2022 - 01/2010
16	Peptides (Polypeptides)IBA 11/2020 - 01/2012
15	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
15	Oxygen (Dioxygen)IBA 01/2022 - 09/2011
15	ApolipoproteinsIBA 01/2021 - 02/2010
14	Biological ProductsIBA 09/2022 - 09/2009
12	CytokinesIBA 01/2022 - 10/2011
12	Therapeutic UsesIBA 12/2021 - 01/2010
12	AndrogensIBA 01/2019 - 01/2009
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2005
10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2013
9	Messenger RNA (mRNA)IBA 11/2022 - 01/2004
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2004
9	LipopolysaccharidesIBA 01/2022 - 09/2015
9	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2004
8	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 01/2016
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 10/2011
8	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2015
8	AntioxidantsIBA 01/2022 - 01/2016
8	Peroxidase (Myeloperoxidase)IBA 01/2022 - 12/2014
8	Hemoglobins (Hemoglobin)IBA 08/2021 - 01/2017
8	Long Noncoding RNAIBA 05/2021 - 01/2017
8	GoldIBA 09/2020 - 11/2016
7	omega-Chloroacetophenone (Mace)IBA 09/2021 - 01/2017
6	VaccinesIBA 11/2022 - 11/2016
6	Bile Acids and Salts (Bile Acids)IBA 06/2022 - 12/2018
6	C-Reactive ProteinIBA 03/2022 - 01/2019
6	CateninsIBA 01/2022 - 10/2010
6	Small Interfering RNA (siRNA)IBA 01/2022 - 07/2005
6	CollagenIBA 01/2021 - 01/2016
6	SolutionsIBA 01/2021 - 10/2010
6	Phosphotransferases (Kinase)IBA 10/2020 - 10/2005
6	ErbB Receptors (EGF Receptor)IBA 08/2020 - 04/2013
6	Neuroprotective AgentsIBA 11/2019 - 01/2016

Therapy/Procedure

74	Therapeutics 05/2022 - 07/2005
13	Ligation 01/2021 - 10/2011
11	Immunotherapy 05/2022 - 11/2016
11	Drug Therapy (Chemotherapy) 03/2022 - 10/2010
11	Resuscitation 01/2022 - 11/2013
9	Percutaneous Coronary Intervention 01/2022 - 12/2017
9	Punctures 01/2021 - 01/2016
8	Transplantation 02/2022 - 01/2009
6	Photothermal Therapy 06/2019 - 11/2016
6	Castration 01/2019 - 06/2010